Table 3.
Lupus Nephritis* | Thrombocytopenia | Neuropsychiatric** | APS | Combined | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Variables | HR | (95% CI) | HR | (95% CI) | HR | (95% CI) | HR | (95% CI) | HR | (95% CI) |
Race/ethnicity | ||||||||||
Non-Hispanic White | reference | reference | reference | reference | reference | |||||
Non-Hispanic Black | 2.4 | (1.6 − 3.8) | 2.3 | (1.1 − 4.4) | 1.5 | (0.8 − 2.9) | 1.5 | (0.7 − 3.0) | 1.6 | (1.1 − 2.2) |
API | 4.3 | (2.9 − 6.4) | 2.3 | (1.3 − 4.2) | 1.1 | (0.6 − 2.0) | 2.5 | (1.4 − 4.4) | 2.4 | (1.8 − 3.2) |
Hispanic | 2.3 | (1.4 −3.8) | 2.2 | (1.1 − 4.7) | 1.0 | (0.4 − 2.5) | 2.6 | (1.3 − 5.1) | 1.4 | (0.9 − 2.1) |
Sex | ||||||||||
Female | reference | reference | reference | reference | reference | |||||
Male | 1.6 | (1.1 − 2.4) | 2.1 | (1.2 − 3.6) | 1.8 | (0.9 − 3.6) | 1.4 | (0.7 − 2.6) | 1.8 | (1.3 − 2.5) |
Age, yr at diagnosis | ||||||||||
≤18 | 1.1 | (0.8 − 1.5) | 1.0 | (0.6 − 1.8) | 1.1 | (0.6 − 2.2) | 1.1 | (0.6 − 1.8) | 0.9 | (0.7 − 1.2) |
19–29 | reference | reference | reference | reference | reference | |||||
30–39 | 0.8 | (0.5 − 1.2) | 0.7 | (0.4 − 1.4) | 0.8 | (0.4 − 1.8) | 0.7 | (0.4 − 1.4) | 0.8 | (0.5 − 1.1) |
40–49 | 1.0 | (0.6 − 1.5) | 0.5 | (0.2 − 1.1) | 1.2 | (0.5 − 2.8) | 0.7 | (0.4 − 1.6) | 0.9 | (0.7 − 1.4) |
50+ | 1.0 | (0.6 – 1.5) | 1.6 | (0.9 − 2.8) | 1.7 | (0.8 − 4.0) | 1.0 | (0.5 − 2.0) | 1.4 | (1.0 − 2.0) |
Calculations based on Cox proportional hazards model that contained each of race/ethnicity, sex, and age at diagnosis.
API = Asian/Pacific Islander, APS = antiphospholipid antibody syndrome, Combined outcome = any of lupus nephritis, thrombocytopenia, neuropsychiatric, or APS. HR = hazard ratio. Higher hazards indicate a shorter time to development of specific manifestations.
Any of the following surrogate labs were used to define lupus nephritis: 24 hour urine for protein > 500mg, 24 hour urine protein/creatinine ratio > 0.5, or spot protein/creatinine ratio > 0.5.
Neuropsychiatric lupus manifestations studied include: seizures, psychosis, and acute confusional state.